Back

Clinical impact of a newly diagnosed cancer in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Comorbidities and risk for CAD CAD and comorbidities ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Shunsuke Sakai

JA Mito Kyodo Hospital, Mito (Japan)

25 More presentations in this session

Presentation thumbnail
Clinical profile, mortality and implications of antithrombotic therapy in coronary ectasia.
Mr A. Marco del Castillo (Madrid, ES)
Abstract
Presentation thumbnail
Expression of the adipocytokine omentin increases in the epicardial adipose tissue of non-obese coronary artery disease patients
Doctor K. Harada (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Assessment of immune mediators in plasma: a new diagnostic tool for detection of coronary artery disease after heart transplantation.
Professor C. Bara (Berlin, DE)
Presentation thumbnail
Long-term prognosis and potential years-of-life lost by acute coronary syndromes
Doctor A. Cordero (Alicante, ES)
Abstract Slides
Presentation thumbnail
the endothelin gene-1 (EDN-1) glu105Glu (rs5369) gene polymorphism in the EDN-1 is associated with risk of developing acute coronary syndrome in mexican patients
Doctor O. Gomez Monterrosas (Puebla, MX)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Comorbidities and risk for CAD

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources